Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Q32 Bio (QTTB) EBITDA Margin (2018 - 2023)

Historic EBITDA Margin for Q32 Bio (QTTB) over the last 6 years, with Q4 2023 value amounting to 1897.72%.

  • Q32 Bio's EBITDA Margin rose 61987200.0% to 1897.72% in Q4 2023 from the same period last year, while for Sep 2024 it was 5690.07%, marking a year-over-year increase of 63361600.0%. This contributed to the annual value of 725.53% for FY2023, which is 34291100.0% up from last year.
  • Latest data reveals that Q32 Bio reported EBITDA Margin of 1897.72% as of Q4 2023, which was up 61987200.0% from 419.47% recorded in Q3 2023.
  • Over the past 5 years, Q32 Bio's EBITDA Margin peaked at 1897.72% during Q4 2023, and registered a low of 9304.81% during Q1 2019.
  • Its 5-year average for EBITDA Margin is 3582.2%, with a median of 4145.07% in 2021.
  • Per our database at Business Quant, Q32 Bio's EBITDA Margin tumbled by -83574300bps in 2019 and then skyrocketed by 62023300bps in 2021.
  • Over the past 5 years, Q32 Bio's EBITDA Margin (Quarter) stood at 4539.79% in 2019, then soared by 33bps to 3041.02% in 2020, then crashed by -38bps to 4192.64% in 2021, then decreased by -3bps to 4301.0% in 2022, then skyrocketed by 144bps to 1897.72% in 2023.
  • Its EBITDA Margin was 1897.72% in Q4 2023, compared to 419.47% in Q3 2023 and 226.99% in Q2 2023.